WT1 Positive
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma (NCT02408016) | Fred Hutchinson Cancer Center | 2015-05-22 |
Track WT1 Positive automatically
Every clearance here is in the API, with alerts when new ones post.